Abstract. A number of viral and eukaryotic proteins which undergo a lipophilic modification by the enzyme N-myristoyltransferase (NMT: NMT1 and NMT2) are required for signal transduction and regulatory functions. We reported a higher expression of NMT2 in most of the cases of cancerous tissues compared to normal tissues by Western blot analysis. Furthermore, protein-protein interaction of NMTs revealed that m-calpain interacts with NMT1 while caspase-3 interacts with NMT2. Our findings provide the first evidence of higher expression of NMT2 in human colorectal adenocarcinomas and the interaction of both forms of NMT with various signaling molecules. In this review, we summarize the recent findings on NMT2 in human colon cancer in our laboratory.
Introduction
Myristoylation is a co-translational lipid modification of proteins (1) in which myristate (a 14-carbon fatty acid) is covalently attached to the amino terminus of various cellular, viral and onco proteins (2) (3) (4) (5) (6) (7) (8) . Cellular myristoylated proteins have diverse biological functions in signal transduction and oncogenesis (2) (3) (4) (5) (6) (7) (8) . The processes of myristoylation is catalyzed by the ubiquitously distributed eukaryotic enzyme N-myristoyltransferase (NMT), which is a member of Glycylpeptide N-tetradecanoyltransferase (GNAT, EC 2.3.1.97) (2) (3) (4) (5) (6) (7) (8) . NMT exists in several distinct forms varying in either apparent molecular weight and/or subcellular distribution (9) (10) (11) (12) (13) . King and Sharma (9) provided the first evidence for the existence of multiple forms of bovine brain NMT. Later, McIlhinney et al (10) also identified two forms of NMT in bovine brain cortex. Subsequently, Glover and Felsted (11) showed that bovine brain NMT exists as a heterogeneous mixture of NMT subunits.
The gene for the NMT enzyme is ubiquitous in all eukaryotes, sharing highly conserved domains across species as diverse as Saccharomyces cerevisiae and humans (14) (15) (16) . Mammals and plants have two genes for NMT, NMT1 and NMT2, while other species such as the fruit fly appear to have only one (12, (17) (18) (19) . The predicted 496-amino acid human NMT1 protein shares 77 and 97% sequence identity with human NMT2 and mouse NMT1 respectively, indicating that NMT1 and NMT2 represent two distinct families of NMT (12) . Two types of NMT, NMT1 and NMT2, were identified and cloned from various sources (12,13).
NMT in cancer
Protein myristoylation is a co-translational process that occurs after the removal of methionine. However, there have been reports documenting post-translational myristoylation of protein such as the pro-apoptotic protein BID (20, 21) . Methionine aminopeptidase (MetAP) is the enzyme responsible for the removal of methionine from the amino-terminus of newly synthesized proteins (22) . We observed elevated MetAP2 expression for the first time in human colorectal adenocarcinomas and various human colon cell lines (HCCLs) (23, 24) . In addition, we have demonstrated the differential expressions of pp60 c-src , MetAP2 and NMT1 in HT29, human colon cell line (24) .
C-Src is overexpressed in a number of human cancers, especially those of colon (25, 26) and breast (27) . The tyrosine kinase activities of N-myristoylated pp60 c-src and pp62
c-yes protein kinases are significantly elevated in primary colorectal adenocarcinoma as well as in their corresponding cell lines relative to those of normal cells (26) (27) (28) . Earlier, we reported that NMT activity is higher in colonic epithelial neoplasms than in normal appearing colonic tissue and that increased NMT activity appears at an early stage in colonic carcinogenesis (29) . Furthermore, we observed that the NMT expression is elevated in human colon (30) and gallbladder carcinomas (31) . Recently, we reported high expressions of both NMT1 and NMT2 in human brain tumors (32) . We discovered and characterized an NMT inhibitor protein 71 (NIP71) (33) . Furthermore, we identified that the NIP71 is homologous to heat shock cognate protein 70 (Hsc70) (34) . Our previous studies have focused on NMT1 and its expression in various tumors. To our knowledge, no studies are available related to NMT2 in colorectal adenocarcinomas.
Expression of NMT2 in human colorectal tissues
We investigated the expression of NMT2 in colorectal carcinoma and observed a high expression of NMT2 in human colorectal adenocarcinoma (35) . Western blot analysis revealed that a high expression of NMT2 in human colorectal tumor tissues compared to normal tissues (Fig. 1A) . The quantitative analysis demonstrated a significant increase in NMT2 expression in colorectal cancer tissues compared to normal mucosa (Fig. 1B) . Interestingly, we observed a high expression of NMT2 in polyps. We demonstrate for the first time a higher expression of NMT2 in colorectal adenocarcinoma patients and HCCLs. These results indicate that the NMT2 gene is upregulated during molecular events that take place during the malignant formation of colon tissues. Higher expression of NMT2 was reported in rat hepatoma cells by dioxin toxicity and the inducible level of NMT2 was a direct consequence of Ah receptor activation (36) . This observation indicates that NMT2 may not be involved in the myristoylation of pp60 c-src , but may have a role in myristoylation of other proteins in colon adenocarcinomas. Further studies are needed to distinguish the regulation of NMT1 and NMT2 on the myristoylation of various proteins in colon carcinogenesis. The specific role of each form of NMT in protein myristoylation has not yet been studied.
Interaction of NMTI and NMT2 with proteases
Recently, the importance of calpain in the metastatic process has received great attention. Calpain-mediated proteolysis represents a major pathway of post-translational modification that influences various aspects of cell physiology including apoptosis, cell migration and cell proliferation (37) (38) (39) . Calpains cause limited proteolysis of substrates, resulting in the alteration of substrate activity. PEST sequences are believed to be the intramolecular signals for rapid proteolytic degradation by m-calpain. Our previous study suggested that bovine cardiac NMT1 has poor PEST regions and the elimination of NMT activity by m-calpain proteolysis occurs in vitro (40) . Protein-protein interactions are controlled by the availability of the component proteins, which are principally controlled by the net effects of synthesis and degradation of proteins. The calpain and ubiquitin-proteasome pathways function as the major proteolytic systems responsible for the regulated degradation of various proteins (41, 42) . Numerous lines of evidence demonstrate that calpains, a family of Ca 2+ -dependent cysteine protease, are involved in oncotic cell death in a variety of models (42) . Recently, we reported that the activity and protein expression of m-calpain was significantly higher in colorectal adenocarcinomas than in normal samples (43) .
We examined the interaction of both forms of NMT with m-calpain and caspase-3 in human colorectal normal and adenocarcinoma tissues and in HT29 by immunoprecipitation analysis (35) . We observed the interaction of NMT1 with m-calpain in normal, tumor and HT29 samples (Fig. 2aA) . Furthermore, the immunoprecipitation analysis of m-calpain using NMT2 antibody revealed no interaction between NMT2 and m-calpain (Fig. 2aA) . The data revealed that m-calpain could interact with NMT1, but not with NMT2. This result indicates that both forms of NMT may regulate differently in cellular signaling. Cross-talk between calpain and caspase proteolytic systems has complicated efforts to determine their distinct roles in apoptotic cell death. It has been observed that calpastatin overexpression decreased calpain activation, increased caspase-3-like activity, and accelerated the appearance of apoptotic nuclear morphology (44) .
The involvement of calpains and caspases in pathological conditions are unclear. However, the endogenous calpain inhibitor, calpsastatin, was degraded not by calpains but by caspases during apoptosis (45) . It may be possible that caspase-3 might indirectly activate calpain via calpastatin degradation. To study the protein-protein interaction of NMTs with caspase-3, we examined immunoprecipitation analysis of caspase-3 with NMT1 and NMT2 antibodies using human normal, tumor and HT29 samples (Fig. 2aB) (35) . We observed that the NMT2 interacts with caspase-3 in normal and cancerous samples whereas, NMT1 failed to interact with caspase-3 (Fig. 2aB) . These data revealed that NMTs may be involved in the calpain/caspase-mediated pathway during the development of cancer. It is worth noting the difference in the interaction of the two forms of NMT with m-calpain and caspase-3. NMT1 was able to interact with m-calpain, but not with NMT2, whereas, NMT2 could interact with caspase-3 but not with m-calpain. It is plausible that a differential regulation exists for NMT1 and NMT2 by m-calpain and caspase-3.
Interaction of NMTs between p53 and Bcl2
Mutations in the p53 gene are among the most common genetic disorders in human cancer, including those originating in the breast, colon, lung and liver (46) . Increased expressions of NMT in p53 mutant cases suggest that wild-type p53 may have a negative regulatory effect on NMT gene expression (31) . It is critical to identify the pathways responsible for the activation and suppression of p53 activity in cancerous cells. The immunoprecipitation analysis of p53 with NMT1 and NMT2 antibodies revealed the interaction of p53 with NMT1 and NMT2 in human normal, tumor and HT29 samples (Fig. 2bA) (35) . Interaction of p53 with NMT1 was more intense in human colorectal adenocarcinoma than in normal mucosa. Similarly, the interaction of p53 with NMT1 in HT29 cells was more significant (Fig. 2bA) . We observed the interaction of p53 with NMT2 in human normal and tumor tissues extracts and in HT29. While, no change in intensity of interaction between NMT2 and p53 was observed across normal and cancerous tissues, a slightly higher interaction occurred in HT29 cells (Fig. 2bA) . These data suggest that NMTs may be involved in the p53 pathway during cancer development.
Bcl2 overexpression leading to inhibition of cell death signaling has been observed as a relatively early event in colorectal cancer development. Several studies of colorectal adenocarcinomas have detected expression of Bcl2 protein using immunohistochemistry (28, (47) (48) (49) (50) (51) (52) . We examined the interaction of Bcl2 with NMT1 and NMT2 by immunoprecipitation analysis in human normal, tumor and HT29 samples (Fig. 2bB) (35) . NMT1 failed to interact with Bcl2 in any of the samples tested (Fig. 2bB) , whereas Bcl2 interacted with NMT2 (Fig. 2bB) . These data suggest that Bcl2 associates with NMT2, but not with NMT1 (35) .
Despite the massive amount of knowledge that has accumulated about p53, there is still much to learn about its role in tumor suppression. Tumors with increased expression of NMT and p53 were associated with poor clinical outcomes as evidenced by their mean survival times (31). Selvakumar et al (35) showed a strong interaction between NMT1 and p53 in colon cancer tissues and in HT29. However, the interaction of NMT2 with p53 was similar in cancerous and normal mucosa. It is critical to identify the pathways responsible for suppression of apoptosis by NMT1 and NMT2 in colon cancer. Bcl2 suppresses apoptosis induced by a wide variety of stimuli in multiple cell types. Our present study sheds light on the interaction of two forms of NMT with Bcl2. The interesting observation was that Bcl2 interacts with NMT2, whereas this apoptotic factor was unable to interact with NMT1 (35) . Further studies are needed to explain the role of NMT1 and NMT2 in the regulation of apoptosis in colon carcinoma.
Conclusion
We demonstrated the overexpression of NMT2 in colorectal cancer tissues as well as in HCCLs employing Western blot analysis. Furthermore, we observed the interaction of different forms of NMT (NMT1 and NMT2) with different cell signalling molecules in colon cancer. NMT1 and NMT2 interact differently with m-calpain and caspase-3. Further work is required to rule out the possibility that myristoylation is regulated by m-calpain and caspase-3 using particular protease inhibitors. Strong protein-protein interaction of NMT1 with p53 was observed in colon cancer tissues and HT29. Currently, we are investigating the specific role of NMT1 and NMT2 by RNAi studies on myristoylation of proteins and their involvement in the regulation of apoptosis.
